Originally published December 18 2005
Medical authorities berate FDA's process for preapproving drugs
by Mike Adams, the Health Ranger, NaturalNews Editor
Marvin M. Lipman, MD, chief medical advisor for Consumers Union and emeritus professor of medicine at New York Medical College, speak with WebMD about the flawed pre-approval process that the FDA uses in looking at prescription drugs, and Lipman revealed that he is equally critical of the negligible surveillance of drugs after the approval process.
Millions of Americans unknowingly risk rare but serious drug side effects, Consumer Reports says.
In its January 2006 issue, the independent consumer magazine points to a dozen common prescription drugs linked to serious risks -- including death.
These risks, the article says, were "undetected or underestimated when the FDA approved them for use."
For people who need them, their benefits outweigh their risks.
What's flawed is the U.S. drug safety system, says Marvin M. Lipman, MD, chief medical advisor for Consumers Union and emeritus professor of medicine at New York Medical College, Valhalla.
"This is a report that criticizes not only the preapproval process, but also the postapproval surveillance system," Lipman tells WebMD.
Once upon a time, the FDA was very slow to approve new drugs.
That changed in the early '90s, when Congress passed the Prescription Drug User Fee Act (PDUFA).
The law gave the FDA deadlines for making approval decisions.
In return, it charged drug companies fees used to hire new drug reviewers.
The Consumer Reports article quotes a former FDA reviewer as saying that the tight deadlines were frustrating.
Indeed, a 2003 HHS survey found that 20% of FDA reviewers said they felt pressured to recommend approval despite reservations.
"The relationship of the FDA to the pharmaceutical industry has to be examined very closely," Lipman says.
"Under the PDUFA law, a lot of money is paid by the drug companies to have their drugs reviewed.
There is something inherently bad about that.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml